Obesity ups odds for dangerous lung clots in COVID-19 patients

Obesity ups odds for dangerous lung clots in COVID-19 patients

(HealthDay)—Obesity makes COVID-19 worse and may lead to deadly blood clots in the lungs, a new study finds.

The researchers said that with COVID-19 may have nearly three times the risk of developing what is known as a pulmonary .

"Clinicians can utilize our findings to aid in determining which patients should have evaluation for pulmonary embolism with pulmonary CT angiography, as the symptoms for COVID-19 and pulmonary embolism overlap," said lead researcher Dr. Neo Poyiadi, from the department of diagnostic radiology at Henry Ford Hospital in Detroit.

"Early detection of pulmonary embolism can allow prompt treatment with anticoagulation and minimize clinical problems," he said.

Hospitalized obese patients with COVID-19 should be evaluated for increases in clotting indicated by a rising D-dimer—a for clotting.

According to the study, 22% of 328 patients suffering from COVID-19 who had a CT scan angiography had a pulmonary embolism.

Researchers also found that patients taking statins to lower cholesterol before coming down with COVID-19 were less likely to have a pulmonary embolism.

"Further studies are needed to determine if statins have a protective effect against pulmonary embolism in COVID-19 patients," Poyiadi said.

Poyiadi added that a recent study suggests that COVID-19 patients should be placed on blood thinners to prevent clotting.

Obesity may make COVID-19 worse because it's associated with an increase in inflammation. Inflammation also increases the risk of clotting.

The report was published online May 14 in the journal Radiology.

Dr. Marc Siegel is a professor of medicine at NYU Langone Medical Center in New York City. He said, "This study underscores a point that's becoming more widely known about COVID-19—that leads to an inflammatory cascade. We know that inflammatory chemicals increase with obesity. That's the suspected mechanism of why obese patients are more at risk for complications."

Inflammation can lead to blood clots, although that's not been proven, he noted.

"The complications of COVID-19 that we've been seeing are inflammation and a cytokine storm, which causes inflammation in the arteries and clots throughout the body—and obesity is a culprit in high-risk patients," Siegel said.

"To say that's why we're seeing more in obese patients is plausible. It's early small numbers, but it's a very important finding and it's not surprising," he said.

What is surprising is it looks like using statins might be helpful. Statins are anti-inflammatories, Siegel noted.

But whether statins are protective is something that would have to be carefully studied, he said. There's no clear-cut reason to start obese patients on statins if they weren't already taking them when they were admitted to the hospital, he added.

Obese patients with COVID-19 need the same care as other patients, Siegel said. That includes anticoagulation. Many of the complications of COVID-19 seem to be caused by clotting, and starting patients on may become a standard treatment.

"We're already starting to look at preventative anticoagulation," he said. "It's already something we're highly aware of, but this study adds evidence to a direct correlation between obesity and , that's what's new here."

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: For more on pulmonary embolism, head to the U.S. National Library of Medicine.
Journal information: Radiology

Copyright © 2020 HealthDay. All rights reserved.

Citation: Obesity ups odds for dangerous lung clots in COVID-19 patients (2020, May 20) retrieved 17 June 2021 from https://medicalxpress.com/news/2020-05-obesity-ups-odds-dangerous-lung.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments